Global Needle-Free Drug Delivery Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI12245436

Publication Date:

December 10, 2024

Pages:

111

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Needle-Free Drug Delivery market size was valued at US$ 9481.2 million in 2023. With growing demand in downstream market, the Needle-Free Drug Delivery is forecast to a readjusted size of US$ 16520 million by 2030 with a CAGR of 8.3% during review period.
The research report highlights the growth potential of the global Needle-Free Drug Delivery market. Needle-Free Drug Delivery are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Needle-Free Drug Delivery. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Needle-Free Drug Delivery market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Needle-Free Drug Delivery market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Needle-Free Drug Delivery market. It may include historical data, market segmentation by Type (e.g., Jet-based, Spring-based), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Needle-Free Drug Delivery market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Needle-Free Drug Delivery market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Needle-Free Drug Delivery industry. This include advancements in Needle-Free Drug Delivery technology, Needle-Free Drug Delivery new entrants, Needle-Free Drug Delivery new investment, and other innovations that are shaping the future of Needle-Free Drug Delivery.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Needle-Free Drug Delivery market. It includes factors influencing customer ' purchasing decisions, preferences for Needle-Free Drug Delivery product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Needle-Free Drug Delivery market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Needle-Free Drug Delivery market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Needle-Free Drug Delivery market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Needle-Free Drug Delivery industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Needle-Free Drug Delivery market.
Market Segmentation:
Needle-Free Drug Delivery market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Jet-based
Spring-based
Laser-based
Segmentation by application
Insulin delivery
Vaccination
Pain management
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Antares Pharma
Pharmajet
Optinose
Valeritas
Crossject
Injex Pharma
3M Pharmaceuticals
Becton Dickinson (BD)
MedImmune
Mystic Pharmaceuticals
Zogenix

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Needle-Free Drug Delivery Market Size 2019-2030
2.1.2 Needle-Free Drug Delivery Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Needle-Free Drug Delivery Segment by Type
2.2.1 Jet-based
2.2.2 Spring-based
2.2.3 Laser-based
2.3 Needle-Free Drug Delivery Market Size by Type
2.3.1 Needle-Free Drug Delivery Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Needle-Free Drug Delivery Market Size Market Share by Type (2019-2024)
2.4 Needle-Free Drug Delivery Segment by Application
2.4.1 Insulin delivery
2.4.2 Vaccination
2.4.3 Pain management
2.5 Needle-Free Drug Delivery Market Size by Application
2.5.1 Needle-Free Drug Delivery Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Needle-Free Drug Delivery Market Size Market Share by Application (2019-2024)
3 Needle-Free Drug Delivery Market Size by Player
3.1 Needle-Free Drug Delivery Market Size Market Share by Players
3.1.1 Global Needle-Free Drug Delivery Revenue by Players (2019-2024)
3.1.2 Global Needle-Free Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Needle-Free Drug Delivery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Needle-Free Drug Delivery by Regions
4.1 Needle-Free Drug Delivery Market Size by Regions (2019-2024)
4.2 Americas Needle-Free Drug Delivery Market Size Growth (2019-2024)
4.3 APAC Needle-Free Drug Delivery Market Size Growth (2019-2024)
4.4 Europe Needle-Free Drug Delivery Market Size Growth (2019-2024)
4.5 Middle East & Africa Needle-Free Drug Delivery Market Size Growth (2019-2024)
5 Americas
5.1 Americas Needle-Free Drug Delivery Market Size by Country (2019-2024)
5.2 Americas Needle-Free Drug Delivery Market Size by Type (2019-2024)
5.3 Americas Needle-Free Drug Delivery Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Needle-Free Drug Delivery Market Size by Region (2019-2024)
6.2 APAC Needle-Free Drug Delivery Market Size by Type (2019-2024)
6.3 APAC Needle-Free Drug Delivery Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Needle-Free Drug Delivery by Country (2019-2024)
7.2 Europe Needle-Free Drug Delivery Market Size by Type (2019-2024)
7.3 Europe Needle-Free Drug Delivery Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Needle-Free Drug Delivery by Region (2019-2024)
8.2 Middle East & Africa Needle-Free Drug Delivery Market Size by Type (2019-2024)
8.3 Middle East & Africa Needle-Free Drug Delivery Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Needle-Free Drug Delivery Market Forecast
10.1 Global Needle-Free Drug Delivery Forecast by Regions (2025-2030)
10.1.1 Global Needle-Free Drug Delivery Forecast by Regions (2025-2030)
10.1.2 Americas Needle-Free Drug Delivery Forecast
10.1.3 APAC Needle-Free Drug Delivery Forecast
10.1.4 Europe Needle-Free Drug Delivery Forecast
10.1.5 Middle East & Africa Needle-Free Drug Delivery Forecast
10.2 Americas Needle-Free Drug Delivery Forecast by Country (2025-2030)
10.2.1 United States Needle-Free Drug Delivery Market Forecast
10.2.2 Canada Needle-Free Drug Delivery Market Forecast
10.2.3 Mexico Needle-Free Drug Delivery Market Forecast
10.2.4 Brazil Needle-Free Drug Delivery Market Forecast
10.3 APAC Needle-Free Drug Delivery Forecast by Region (2025-2030)
10.3.1 China Needle-Free Drug Delivery Market Forecast
10.3.2 Japan Needle-Free Drug Delivery Market Forecast
10.3.3 Korea Needle-Free Drug Delivery Market Forecast
10.3.4 Southeast Asia Needle-Free Drug Delivery Market Forecast
10.3.5 India Needle-Free Drug Delivery Market Forecast
10.3.6 Australia Needle-Free Drug Delivery Market Forecast
10.4 Europe Needle-Free Drug Delivery Forecast by Country (2025-2030)
10.4.1 Germany Needle-Free Drug Delivery Market Forecast
10.4.2 France Needle-Free Drug Delivery Market Forecast
10.4.3 UK Needle-Free Drug Delivery Market Forecast
10.4.4 Italy Needle-Free Drug Delivery Market Forecast
10.4.5 Russia Needle-Free Drug Delivery Market Forecast
10.5 Middle East & Africa Needle-Free Drug Delivery Forecast by Region (2025-2030)
10.5.1 Egypt Needle-Free Drug Delivery Market Forecast
10.5.2 South Africa Needle-Free Drug Delivery Market Forecast
10.5.3 Israel Needle-Free Drug Delivery Market Forecast
10.5.4 Turkey Needle-Free Drug Delivery Market Forecast
10.5.5 GCC Countries Needle-Free Drug Delivery Market Forecast
10.6 Global Needle-Free Drug Delivery Forecast by Type (2025-2030)
10.7 Global Needle-Free Drug Delivery Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Antares Pharma
11.1.1 Antares Pharma Company Information
11.1.2 Antares Pharma Needle-Free Drug Delivery Product Offered
11.1.3 Antares Pharma Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Antares Pharma Main Business Overview
11.1.5 Antares Pharma Latest Developments
11.2 Pharmajet
11.2.1 Pharmajet Company Information
11.2.2 Pharmajet Needle-Free Drug Delivery Product Offered
11.2.3 Pharmajet Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pharmajet Main Business Overview
11.2.5 Pharmajet Latest Developments
11.3 Optinose
11.3.1 Optinose Company Information
11.3.2 Optinose Needle-Free Drug Delivery Product Offered
11.3.3 Optinose Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Optinose Main Business Overview
11.3.5 Optinose Latest Developments
11.4 Valeritas
11.4.1 Valeritas Company Information
11.4.2 Valeritas Needle-Free Drug Delivery Product Offered
11.4.3 Valeritas Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Valeritas Main Business Overview
11.4.5 Valeritas Latest Developments
11.5 Crossject
11.5.1 Crossject Company Information
11.5.2 Crossject Needle-Free Drug Delivery Product Offered
11.5.3 Crossject Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Crossject Main Business Overview
11.5.5 Crossject Latest Developments
11.6 Injex Pharma
11.6.1 Injex Pharma Company Information
11.6.2 Injex Pharma Needle-Free Drug Delivery Product Offered
11.6.3 Injex Pharma Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Injex Pharma Main Business Overview
11.6.5 Injex Pharma Latest Developments
11.7 3M Pharmaceuticals
11.7.1 3M Pharmaceuticals Company Information
11.7.2 3M Pharmaceuticals Needle-Free Drug Delivery Product Offered
11.7.3 3M Pharmaceuticals Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 3M Pharmaceuticals Main Business Overview
11.7.5 3M Pharmaceuticals Latest Developments
11.8 Becton Dickinson (BD)
11.8.1 Becton Dickinson (BD) Company Information
11.8.2 Becton Dickinson (BD) Needle-Free Drug Delivery Product Offered
11.8.3 Becton Dickinson (BD) Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Becton Dickinson (BD) Main Business Overview
11.8.5 Becton Dickinson (BD) Latest Developments
11.9 MedImmune
11.9.1 MedImmune Company Information
11.9.2 MedImmune Needle-Free Drug Delivery Product Offered
11.9.3 MedImmune Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 MedImmune Main Business Overview
11.9.5 MedImmune Latest Developments
11.10 Mystic Pharmaceuticals
11.10.1 Mystic Pharmaceuticals Company Information
11.10.2 Mystic Pharmaceuticals Needle-Free Drug Delivery Product Offered
11.10.3 Mystic Pharmaceuticals Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Mystic Pharmaceuticals Main Business Overview
11.10.5 Mystic Pharmaceuticals Latest Developments
11.11 Zogenix
11.11.1 Zogenix Company Information
11.11.2 Zogenix Needle-Free Drug Delivery Product Offered
11.11.3 Zogenix Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Zogenix Main Business Overview
11.11.5 Zogenix Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂